Updated:
Scopus BioPharma Inc.
Scopus BioPharma Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001772028, and its reported industry...
Overview
Scopus BioPharma Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001772028, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2023-04-14, it reported annual revenue of USD 0; net income of USD -11,609,827; total assets of USD 392,265 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Scopus BioPharma Inc.
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- New York, NY, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001772028
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2022USD | $0 | -$11.6M | $392,265 | $124,575 | -$8.1M | |
| FY2021USD | $0 | -$27.0M | $8.2M | $7.9M | -$11.4M | |
| FY2020USD | $0 | -$10.9M | $2.0M | $1.8M | -$2.5M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 10-Q | 10-Q | ||
| DEF 14A | DEF 14A | ||
| 10-Q | 10-Q | ||
| 10-K/A | 10-K/A | ||
| 10-K | 10-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Scopus BioPharma Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.